e-learning
resources
Courses
2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Risk stratification of PE and evaluation of the right ventricle
D. Jiménez
Source:
ERS Course 2019 - Masterclass in pulmonary embolism
Number:
2
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Jiménez. Risk stratification of PE and evaluation of the right ventricle. ERS Course 2019 - Masterclass in pulmonary embolism
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Comparison of acute phase reactant pentraksin-3 and inflammatory parameters in acute and stable pulmonary embolism
Features of patients newly diagnosed pulmonary embolism during COVID pneumonia
Diagnosis and treatment of chronic pulmonary embolism
Related content which might interest you:
Cardiac MRI right atrial area measurement thresholds for risk stratification in patients with PAH
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020
Can right ventricle imaging improve risk stratification in pulmonary arterial hypertension?
Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management
Year: 2021
Systemic Coronary Risk Evaluation and pulmonary hypertension, right and left ventricular dysfunction in patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Prognostic value of right ventricular dilatation in patients with low risk pulmonary embolism
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017
Echocardiographic parameters of right ventricular dysfunction in pulmonary hypertension. Usefulness of speckle tracking longitudinal strain of the right ventricle
Source: Annual Congress 2010 - Pulmonary vascular diseases
Year: 2010
CT pulmonary angiography-derived right atrial area can risk stratify patients with PAH and PH
Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update
Year: 2019
Assessment of left ventricular function in COPD
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012
The role of the right ventricle in pulmonary arterial hypertension
Source: Eur Respir Rev 2011; 20: 243-253
Year: 2011
Risk factors for mortality in right ventricular failure and pulmonary arterial hypertension
Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine
Year: 2019
Agreement of right ventricular enlargement assessed by CT angiogram for risk stratifying normotense patients with acute symptomatic pulmonary embolism
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010
Prognostic value of right ventricular dilatation in patients with low-risk pulmonary embolism
Source: Eur Respir J, 50 (6) 1701611; 10.1183/13993003.01611-2017
Year: 2017
Prognostic value of right ventricular transverse wall motion in pulmonary arterial hypertension
Source: Annual Congress 2009 - Chest imaging in evolution: new techniques and new possibilities
Year: 2009
Echocardiographic assessment of pulmonary hypertension: standard operating procedure
Source: Eur Respir Rev 2012 21:239-248
Year: 2012
In patients with intermediate-low risk pulmonary embolism: cardiac enzyme or right ventricle dysfunction or sPESI
Source: International Congress 2017 – Prognostic factors and outcomes in pulmonary embolism
Year: 2017
Risk stratification of pulmonary embolism: clinical evaluation, biomarkers or both?
Source: Eur Respir J 2015; 46: 1551-1553
Year: 2015
Assessment of atrial arrhythmogenic risk factors with body surface potential mapping in COPD patients
Source: Eur Respir J 2005; 26: Suppl. 49, 351s
Year: 2005
Evaluation of right ventricular overload with the ratio of right ventricular end-diastolic area to left ventricular end-diastolic area in precapillary pulmonary hypertension: A cardiac MRI and catheterization study
Source: Annual Congress 2010 - Pulmonary circulation I
Year: 2010
The evaluation of right and left ventricular dysfunction in COPD patients with pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 250s
Year: 2001
Measuring the effects of treatment in patients with PAH: should we image the right ventricle?
Source: Eur Respir J, 49 (6) 1700805; 10.1183/13993003.00805-2017
Year: 2017
Evaluation of right atrium remodeling in patients with COPD complicated by pulmonary artery hypertension
Source: Annual Congress 2010 - State of the art imaging
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept